Effects of histone deacetylase inhibitors on rat mesangial cells

Ilya Freidkin, Michal Herman, Ana Tobar, Avry Chagnac, Yaacov Ori, Asher Korzets, Uzi Gafter*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

20 Scopus citations


Glomerular mesangial cells (MCs) proliferate and produce extracellular matrix proteins in many progressive renal diseases. Recently, histone deacetylase inhibitors (HDIs) were shown to have antiproliferative and antifibrogenic effects in some in vitro and in vivo models. Using the [3H]-thymidine incorporation test, we have found that the HDI trichostatin A (TSA) effectively inhibits MC growth at nontoxic nanomolar concentrations. Similarly, the HDI valproic acid also inhibited MCs proliferation. Cell-cycle analysis indicated an arrest in G0/G1 phase in response to TSA, which was accompanied by elevation in synthesis of the cyclin-dependent kinase inhibitors (CDKIs) p21/Waf1 and p27/Kip1. TSA treatment suppressed α-smooth muscle actin, transforming growth factor-β1, and collagen protein synthesis by MCs and induced myofibroblast-like appearance of proliferating MCs. In the in vivo model of the anti-Thy1.1-induced glomerulonephritis, TSA and valproic acid treatments significantly suppressed proteinuria. Collectively, these data suggest a therapeutic potential for HDIs in the treatment of mesangial proliferative diseases and glomerulosclerosis.

Original languageEnglish
Pages (from-to)F426-F434
JournalAmerican Journal of Physiology - Renal Physiology
Issue number2
StatePublished - Feb 2010


  • Collagen IV
  • Mesangial cells
  • Proliferation
  • Smooth muscle α-actin
  • Trichostatin A
  • Valproic acid


Dive into the research topics of 'Effects of histone deacetylase inhibitors on rat mesangial cells'. Together they form a unique fingerprint.

Cite this